Roche agrees for Sanofi to be responsible for the OTC marketing and distribution of Tamiflu in the US market, as it works on approval for its Xofluza competitor product.
Tamiflu shortens the duration of influenza symptoms by only half a day, does not stop person-to-person spread and increases the risk of nausea say the authors of a new review who want Governments to rethink stockpiling neuraminidase inhibitors.
Japan will only be receiving 50 per cent of its usual supply of the
blockbuster flu drug Tamiflu (oseltamivir) this year, thanks to
significantly reduced demand following reports of suicidal
behaviour in adolescents taking the medication.
Roche has just had the child-size, lower strength version of its
blockbuster flu treatment Tamiflu (oseltamivir) approved by EU
authorities, though possibly just a little too late for this year's
flu season.
Roche has boosted annual manufacturing capacity for Tamiflu
(oseltamivir phosphate) to 80m treatment courses, as demand for the
flu drug shows no sign of abating.
China's State Food and Drug Administration (SFDA) has authorised
Shanghai Sunve Pharmaceutical and Yichang Changjiang Pharmaceutical
to produce a licensed version of Roche's Tamiflu (oseltamivir
phosphate), the first such...
Responding to surging demand for its flu drug Tamiflu, Roche has
announced it is expanding its external contractors to fifteen in
nine different countries, as its needs for intermediates and
finished product increase.
With the aim of meeting government's needs for pandemic planning,
Roche has announced it is on track to produce 300 million Tamiflu
treatments annually from 2007, after stepping up its production
capacity.